NF-κB activation in patients with COPD occurs in response to inflammatory mediators such as IL-1β and TNF-α or due to activation of Toll-like receptors (TLRs) following bacterial or viral infections (Edwards et al., 2009). This evidence concerns the gene NFKB1 and viral infectious disease.